新生儿重症监护病房之间新生儿用药差异巨大是常见现象:是时候达成共识了?
该多中心研究纳入荷兰4个新生儿重症监护病房12个月内收治的1491例新生儿(胎龄范围23+6至42+2周),共32182个患者日、181种药物、10895张处方,其中23%与新生儿年龄相关超说明书。抗感染药物处方最多(3161张,4%超说明书);神经系统药物2500张处方中31%超说明书。神经系统药物、血液和血液形成器官药物、心血管药物在病房间差异最大,每1000例患者各ATC类别总处方数范围分别为919-2278、554-1465、238-952。作者认为新生儿药物研究应高度重视,以保证安全适当的药物和最佳治疗。
要点
- 荷兰4个新生儿重症监护病房12个月共1491例新生儿,10895张处方中23%与新生儿年龄相关超说明书。
- 抗感染药物处方最多(3161张),其中仅4%与新生儿年龄相关超说明书。
- 神经系统药物2500张处方中31%与新生儿年龄相关超说明书,为超说明书比例最高的类别之一。
- 每1000例患者总处方数在病房间差异:神经系统药物919-2278、血液和血液形成器官药物554-1465、心血管药物238-952。
- 超说明书比例最高的药物类别(心血管和神经系统药物)在病房间用药差异最大。
适用人群与场景
- 荷兰4个新生儿重症监护病房12个月内收治的新生儿,胎龄范围23+6至42+2周。
研究设计与关键结果
- 多中心研究,纳入4个新生儿重症监护病房12个月内收治的1491例新生儿(胎龄23+6至42+2周),共32182个患者日、181种药物、10895张处方。
- 10895张处方中23%与新生儿年龄相关超说明书。
- 抗感染药物处方最多,共3161张,其中4%与新生儿年龄相关超说明书。
- 神经系统药物共2500张处方,其中31%与新生儿年龄相关超说明书。
- 每1000例患者各ATC类别总处方数在病房间的范围:神经系统药物919-2278,血液和血液形成器官药物554-1465,心血管药物238-952。
- 比较了疼痛、插管、惊厥和低血压四个常见用药指征的治疗方案。
证据类型、等级与局限
- 证据类型:多中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为新生儿药物研究应高度重视,以保证安全适当的药物和最佳治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIMS: Evidence for drug use in newborns is sparse, which may cause large differences in drug prescriptions. We aimed to investigate the differences between neonatal intensive care units (NICUs) in the Netherlands in currently prescribed drugs.
METHODS: This multicentre study included neonates admitted during 12 months to four different NICUs. Drugs were classified in accordance with the Anatomical Therapeutic Chemical (ATC) classification system and assessed for on/off-label status in relation to neonatal age. The treatment protocols for four common indications for drug use were compared: pain, intubation, convulsions and hypotension.
RESULTS: A total of 1491 neonates (GA range 23+6 -42+2 weeks) were included with a total of 32 182 patient days, 181 different drugs and 10 895 prescriptions of which 23% was off-label in relation to neonatal age. Overall, anti-infective drugs were most frequently used with a total of 3161 prescriptions, of which 4% was off-label in relation to neonatal age. Nervous system drugs included 2500 prescriptions of which 31% was off-label in relation to neonatal age. Nervous system drugs, blood and blood forming organs, and cardiovascular drugs showed the largest differences between NICUs with ranges of 919-2278, 554-1465, and 238-952 total prescriptions per 1000 patients per ATC class, respectively.
CONCLUSIONS: We showed that drug use varies widely in neonatal clinical practice. The drug classes with the highest proportion of off-label drugs in relation to neonatal age showed the largest differences between NICUs, i.e. cardiovascular and nervous system drugs. Drug research in neonates should receive high priority to guarantee safe and appropriate medicines and optimal treatment.
参考来源
- Flint RB, van Beek F, Andriessen P, et al. Large differences in neonatal drug use between NICUs are common practice: time for consensus? Br J Clin Pharmacol. 2018. PMID: 29624207. doi:10.1111/bcp.13563
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。